Traditional Medicinals, a leading herbal tea company based in the United States, has been at the forefront of the herbal wellness industry since its founding in 1974. With its headquarters in Sebastopol, California, the company operates primarily across North America, focusing on the development of high-quality, sustainably sourced herbal products. Renowned for its commitment to traditional herbal practices, Traditional Medicinals offers a diverse range of teas that cater to various health needs, including digestive support, relaxation, and immune health. Their unique approach combines time-honoured herbal knowledge with modern science, ensuring efficacy and quality. As a pioneer in the herbal tea market, Traditional Medicinals has achieved significant recognition, including numerous awards for its innovative products and sustainable practices, solidifying its position as a trusted name in natural wellness.
How does Traditional Medicinals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Traditional Medicinals's score of 41 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Traditional Medicinals reported total carbon emissions of approximately 1,013,680 kg CO2e, comprising 59,340 kg CO2e from Scope 1, 34,340 kg CO2e from Scope 2, and a significant 928,000 kg CO2e from Scope 3, specifically from employee commuting. This marks a notable increase in emissions compared to 2022, where the company recorded 76,150 kg CO2e from Scope 1 and Scope 2 combined, without disclosing Scope 3 emissions. Traditional Medicinals has set ambitious climate commitments, aiming to achieve a 100% reduction in Scope 1, 2, and 3 emissions by 2050, using 2020 as the baseline year. Additionally, the company has committed to reducing Scope 1 and Scope 2 emissions by 42% by 2030. These targets are aligned with the Science Based Targets initiative (SBTi) and are classified as consistent with limiting global warming to 1.5°C. The company's long-term strategy includes reaching net-zero emissions by 2050, reflecting a comprehensive approach to sustainability across its operations. Traditional Medicinals' commitments demonstrate a proactive stance in addressing climate change and reducing its overall carbon footprint.
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 64,680 | 00,000 | 00,000 | 00,000 | 00,000 | 00,000 |
| Scope 2 | 18,620 | 00,000 | 00,000 | 00,000 | 00,000 | 00,000 |
| Scope 3 | - | - | - | - | - | 000,000 |
The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Employee Commuting" representing nearly all of their reported Scope 3 footprint.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Traditional Medicinals has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


Common questions about Traditional Medicinals's sustainability data and climate commitments